preCharge News FLORIDA — Healthcare stocks were among the biggest losers on the Stoxx 600 on Tuesday, with the regional Stoxx Healthcare index down 1.5% by 9 a.m. London time.

Novo Nordisk and Zealand Pharma, both down by around 8.4%, tumbled to the bottom of the Stoxx 600 index after U.S. rival Eli Lilly posted positive results from a late-stage trial of its oral weight loss drug orforglipron.